Phase II, multicentre study evaluating cisplatin (P), epirubicin (E) and vinorelbine (V) as first line chemotherapy (CHT) in advanced breast cancer (ABC): A new promise

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 761-761
Author(s):  
S. Barni ◽  
M. T. Ionta ◽  
R. Labianca ◽  
A. Zaniboni ◽  
A. Ardizzoia ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Multicentre Study ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Advanced Breast ◽  
First Line ◽  
Line Chemotherapy

81 P - Epirubicin (EPI) + navelbine (NVB) as first line chemotherapy in advanced breast cancer (ABC) patients (PTS): a multicentric phase II study

1996 ◽  
Vol 32 ◽  
pp. S17
Author(s):  
E. Baldini ◽  
C. Tibaldi ◽  
M. Da Prato ◽  
A. Chiavacci ◽  
M. Di Lielo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
First Line ◽  
Line Chemotherapy

A Randomized, Double-Blind, Phase II Study of Two Doses of Pemetrexed as First-Line Chemotherapy for Advanced Breast Cancer

2007 ◽  
Vol 13 (12) ◽  
pp. 3652-3659 ◽  
Author(s):  
Antonio Llombart-Cussac ◽  
Miguel Martin ◽  
Nadia Harbeck ◽  
Rodica M. Anghel ◽  
Alexandra E. Eniu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
First Line ◽  
Double Blind ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document